So the bad news is European (Stoxx 600) earnings estimates came in modestly in the past week. The good news is, they are still holding at double digit growth moving forward: Q4 2019 +10.2%, Q1 2020 +15.8%, Q2 2020 +7.5%, and Q3 2020 +15.4%. Continue reading “European Earnings Looking for Double Digit Growth…”
Unusual Options Activity – BioMarin Pharmaceutical Inc. (BMRN)
Today some institution/fund purchased 679 contracts of Jan 2020 $80 strike calls (or the right to buy 67,900 shares of BioMarin Pharmaceutical Inc. (BMRN) at $80). The open interest was just 137 prior to this purchase. Continue reading “Unusual Options Activity – BioMarin Pharmaceutical Inc. (BMRN)”
Where is money flowing today?
Insider Buying in Prudential Financial, Inc. (PRU)
Hedge Fund Trade Tip (PIN) – Position Idea Notification
Be in the know. 10 key reads for Thursday…
- Walmart rolls out unlimited grocery delivery subscription ()
- ECB cuts key rate, to restart bond purchases (Reuters)
- Treasury Secretary Mnuchin says there’s no plan for Trump to meet Iran’s Rouhani at this time (CNBC)
- Trump says China will be buying ‘large amounts’ of US agricultural products (CNBC)
- Nearly half of stock pickers beat their passive peers over the last year (CNBC)
- T. Boone Pickens, the ‘Oracle of Oil,’ corporate raider and billionaire philanthropist, dies at 91 (CNBC)
- Here’s What We Know About How Drugs Are Priced — And What We Don’t ()
- Dividends Are Now Part of the Oil-Stock Playbook (Barron’s)
- Major Biotechs Scare Off Short Sellers (24/7 Wall Street)
- How David Swensen Made Yale Fabulously Rich (Bloomberg)
AAII Sentiment Survey Results: Bulls Awakening from Siesta…
Over the past few weeks we have suggested stepping in as a buyer when everyone else was selling stocks and running into bonds. Continue reading “AAII Sentiment Survey Results: Bulls Awakening from Siesta…”
Unusual Options Activity – Gilead Sciences, Inc. (GILD)
Today some institution/fund purchased 540 contracts of January 2020 $40 strike calls (or the right to buy 54,000 shares of Gilead Sciences, Inc. (GILD) at $40). The open interest was just 128 prior to this purchase. Continue reading “Unusual Options Activity – Gilead Sciences, Inc. (GILD)”
